REFERENCES
2. Bhattacharya K. Investigation and management of the hepatic glycogen storage diseases. Transl Pediatr 2015;4:240-8.
3. Moses SW, Wanderman KL, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 1989;148:764-6.
4. Tada H, Kurita T, Ohe T, Shimomura K, Ishihara T, et al. Glycogen storage disease type III associated with ventricular tachycardia. Am Heart J 1995;130:911-2.
5. Humbert M, Labrune PH, Simonneau G. Severe pulmonary arterial hypertension in type 1 glycogen storage disease. Eur J Pediatr 2002;161:S93-6.
6. Humbert M, Labrune P, Sitbon O, Le Gall C, Callebert J, et al. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J 2002;20:59-65.
7. Derks TG, van Rijn M. Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions. J Inherit Metab Dis 2015;38:537-43.
8. Rake JP, Visser G, Labrune P, Leonard P, Ullrich K, et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002;161:S20-S34.
9. Greenea HL, Swift LL, Knapp HR. Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease. J Pediatr 1991;119:398-403.
10. Fernandes J, Alaupovic P, Wit JM. Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Pediatr Res 1989;25:327-31.
11. Bandsma RH, Smit GP, Kuipers F. Disturbed lipid metabolism in glycogen storage disease type 1. Eur J Pediatr 2002;161:S65-9.
12. Bandsma RH, Prinsen BH, van Der Velden Mde S, Rake JP, Boer T, et al. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res 2008;63:702-7.
13. Sever S, Weinstein DA, Wolfsdorf J, Gedik R, Schaefer EJ. Glycogen storage disease type 1a: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism. J Clin Lipidol 2012;6:596-600.
14. Carvalho PM, Silva NJ, Dias PG. Glycogen storage disease type 1a - a secondary cause for hyperlipidemia: report of five cases. J Diabetes Metab Disord 2013;12:25.
15. Bernier AV, Sentner CP, Correia CE, Theriaque DW, Shuster JJ, et al. Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control. J Inherit Metab Dis 2008;31:729-32.
16. Zhang PY, Xu X, Li XC. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci 2014;18:3091-6.
17. Wittensteina B, Kleina M, Finckha B, Ullrich K, Kohlschütter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 2002;33:103-10.
18. Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, et al. Vascular dysfunction in glycogen storage disease type I. J Pediatr 2009;154:588-91.
19. Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, et al. Vascular dysfunction in glycogen storage disease type I. J Pediatr 2009;154:588-91.
20. Ubels FL, Rake JP, Slaets JP, Smit GP, Smit AJ. Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr 2002;161:S62-4.
21. Yekeler E, Dursun M, Emeksiz E, Akkoyunlu M, Akyol Y, et al. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III. Turk J Pediatr 2007;49:115-9.
22. Goulart JM, Yoo JY, Kirchoff-Torres KF, Delman BN, Tuhrim S. Ischemic stroke in an adult with glycogen storage disease type I. J Clin Neurosci 2010;17:1467-9.
23. Boudjemline AM, Petit F, Buron HA, Eberschweiler TP, Gajdos V, et al. Glycogen storage disease type I (GSD I). Atlas Genet Cytogenet Oncol Haematol 2012;16:860-3.
24. Goldberg RB. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes. Am J Manag Care 2000;8:S682-91.
25. Jeppesen J, Hein HO, Suadicany P, Geintellberg F. Triglycerides concentration and ischaemic heart disease: an eight-year follow-up in the copenhagen male study. Circulation 1998;97:1029-36.
